Indegene Statistics
Total Valuation
Indegene has a market cap or net worth of INR 139.33 billion. The enterprise value is 126.09 billion.
| Market Cap | 139.33B |
| Enterprise Value | 126.09B |
Important Dates
The next estimated earnings date is Wednesday, October 28, 2026.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | Jul 31, 2026 |
Share Statistics
Indegene has 240.90 million shares outstanding. The number of shares has increased by 0.16% in one year.
| Current Share Class | 240.90M |
| Shares Outstanding | 240.90M |
| Shares Change (YoY) | +0.16% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 25.89% |
| Owned by Institutions (%) | 13.98% |
| Float | 102.23M |
Valuation Ratios
The trailing PE ratio is 34.82 and the forward PE ratio is 24.87. Indegene's PEG ratio is 0.96.
| PE Ratio | 34.82 |
| Forward PE | 24.87 |
| PS Ratio | 3.65 |
| PB Ratio | 4.44 |
| P/TBV Ratio | 9.16 |
| P/FCF Ratio | 22.97 |
| P/OCF Ratio | 21.41 |
| PEG Ratio | 0.96 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.04, with an EV/FCF ratio of 20.79.
| EV / Earnings | 31.45 |
| EV / Sales | 3.31 |
| EV / EBITDA | 20.04 |
| EV / EBIT | 25.56 |
| EV / FCF | 20.79 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.25 |
| Debt / FCF | 0.26 |
| Interest Coverage | 26.39 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 20.73% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 8.36% |
| Revenue Per Employee | 8.13M |
| Profits Per Employee | 855,345 |
| Employee Count | 4,687 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Indegene has paid 1.25 billion in taxes.
| Income Tax | 1.25B |
| Effective Tax Rate | 23.73% |
Stock Price Statistics
The stock price has increased by +4.09% in the last 52 weeks. The beta is 0.75, so Indegene's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | +4.09% |
| 50-Day Moving Average | 545.88 |
| 200-Day Moving Average | 511.62 |
| Relative Strength Index (RSI) | 53.06 |
| Average Volume (20 Days) | 685,163 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Indegene had revenue of INR 38.13 billion and earned 4.01 billion in profits. Earnings per share was 16.61.
| Revenue | 38.13B |
| Gross Profit | 37.35B |
| Operating Income | 4.93B |
| Pretax Income | 5.26B |
| Net Income | 4.01B |
| EBITDA | 5.93B |
| EBIT | 4.93B |
| Earnings Per Share (EPS) | 16.61 |
Balance Sheet
The company has 14.81 billion in cash and 1.58 billion in debt, with a net cash position of 13.23 billion or 54.92 per share.
| Cash & Cash Equivalents | 14.81B |
| Total Debt | 1.58B |
| Net Cash | 13.23B |
| Net Cash Per Share | 54.92 |
| Equity (Book Value) | 31.39B |
| Book Value Per Share | 130.29 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 6.51 billion and capital expenditures -443.00 million, giving a free cash flow of 6.07 billion.
| Operating Cash Flow | 6.51B |
| Capital Expenditures | -443.00M |
| Depreciation & Amortization | 991.75M |
| Net Borrowing | -399.00M |
| Free Cash Flow | 6.07B |
| FCF Per Share | 25.18 |
Margins
Gross margin is 97.96%, with operating and profit margins of 12.94% and 10.51%.
| Gross Margin | 97.96% |
| Operating Margin | 12.94% |
| Pretax Margin | 13.79% |
| Profit Margin | 10.51% |
| EBITDA Margin | 15.54% |
| EBIT Margin | 12.94% |
| FCF Margin | 17.28% |
Dividends & Yields
This stock pays an annual dividend of 2.25, which amounts to a dividend yield of 0.38%.
| Dividend Per Share | 2.25 |
| Dividend Yield | 0.38% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.16% |
| Shareholder Yield | 0.21% |
| Earnings Yield | 2.88% |
| FCF Yield | 4.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Indegene is 620.63, which is 6.93% higher than the current price. The consensus rating is "Buy".
| Price Target | 620.63 |
| Price Target Difference | 6.93% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 17.24% |
| EPS Growth Forecast (3Y) | 22.36% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |